Nasus Pharma
NSRX · Tel Aviv, Israel
Works in Immunology · Infectious disease · Psychiatry · Respiratory
Nasus Pharma is a clinical trial sponsor based in Tel Aviv, Israel, listed as NSRX. It has 3 active clinical trials with 92 planned participants, in Immunology, Infectious disease, Psychiatry and Respiratory. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Financials · NSRX
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Nasus Pharma
Nasus Pharma is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 92 planned participants, in Immunology, Infectious disease, Psychiatry, Respiratory. Since 2021 it has completed 4 trials and stopped 0 early.
Nasus Pharma is based in Tel Aviv, Israel and is listed as NSRX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Nasus Pharma; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-09.
Approve Suite is not affiliated with Nasus Pharma.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.